Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D D Christ

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Journal of Clinical Pharmacology|May 1, 1995
Human plasma protein binding of the angiotensin II receptor antagonist losartan potassium (DuP 753/MK 954) and its pharmacologically active metabolite EXP3174D D Christ
The Journal of Physiology|February 1, 1971
Site of adrenaline blockade in the superior cervical ganglion of the rabbitD D Christ, S Nishi
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1989
Stereoselective sulfation of R,S-4'-hydroxypropranolol by canine hepatic cytosol and partially purified phenolsulfotransferasesD D Christ, T Walle
British Journal of Pharmacology|February 1, 1971
Effects of adrenaline on nerve terminals in the superior cervical ganglion of the rabbitD D Christ, S Nishi
Archives Internationales De Pharmacodynamie Et De Therapie|June 1, 1982
Ganglionic blockade by procaine in the presence of pentobarbital and diethyl etherD D Christ, D R Watts
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 31, 1998
In vitro and in vivo effects of the arylamine human immunodeficiency virus protease inhibitor 4R-(4alpha,5alpha,6beta, 7beta)-1-[(3-(1-imidazoylcarbamoyl)phenyl)methyl]-3-[(3-aminophenyl)m ethyl]hexahydro-5,6-dihydroxy-4,7-bis(phenylmethyl)-2H-1, 3-diazepin-2-one (SD894) on rat hepatic cytochrome P450 2B and 3AM F Grubb, S Diamond, D D Christ
European Journal of Pharmacology|September 22, 1992
Enhancement of losartan (DuP 753)-induced angiotensin II receptor antagonism by PD123177 in ratsP C Wong, D D Christ, P B Timmermans
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1988
Potential metabolic basis for enflurane hepatitis and the apparent cross-sensitization between enflurane and halothaneD D Christ, H Satoh, J G Kenna, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1988
Metabolic basis for a drug hypersensitivity: antibodies in sera from patients with halothane hepatitis recognize liver neoantigens that contain the trifluoroacetyl group derived from halothaneJ G Kenna, H Satoh, D D Christ, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 11, 1990
Pharmacokinetics and metabolism of the pharmacologically active 4'-hydroxylated metabolite of propranolol in the dogD D Christ, U K Walle, J E Oatis, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Journal of Clinical Pharmacology|May 1, 1995
Human plasma protein binding of the angiotensin II receptor antagonist losartan potassium (DuP 753/MK 954) and its pharmacologically active metabolite EXP3174D D Christ
The Journal of Physiology|February 1, 1971
Site of adrenaline blockade in the superior cervical ganglion of the rabbitD D Christ, S Nishi
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1989
Stereoselective sulfation of R,S-4'-hydroxypropranolol by canine hepatic cytosol and partially purified phenolsulfotransferasesD D Christ, T Walle
British Journal of Pharmacology|February 1, 1971
Effects of adrenaline on nerve terminals in the superior cervical ganglion of the rabbitD D Christ, S Nishi
Archives Internationales De Pharmacodynamie Et De Therapie|June 1, 1982
Ganglionic blockade by procaine in the presence of pentobarbital and diethyl etherD D Christ, D R Watts
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 31, 1998
In vitro and in vivo effects of the arylamine human immunodeficiency virus protease inhibitor 4R-(4alpha,5alpha,6beta, 7beta)-1-[(3-(1-imidazoylcarbamoyl)phenyl)methyl]-3-[(3-aminophenyl)m ethyl]hexahydro-5,6-dihydroxy-4,7-bis(phenylmethyl)-2H-1, 3-diazepin-2-one (SD894) on rat hepatic cytochrome P450 2B and 3AM F Grubb, S Diamond, D D Christ
European Journal of Pharmacology|September 22, 1992
Enhancement of losartan (DuP 753)-induced angiotensin II receptor antagonism by PD123177 in ratsP C Wong, D D Christ, P B Timmermans
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1988
Potential metabolic basis for enflurane hepatitis and the apparent cross-sensitization between enflurane and halothaneD D Christ, H Satoh, J G Kenna, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1988
Metabolic basis for a drug hypersensitivity: antibodies in sera from patients with halothane hepatitis recognize liver neoantigens that contain the trifluoroacetyl group derived from halothaneJ G Kenna, H Satoh, D D Christ, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 11, 1990
Pharmacokinetics and metabolism of the pharmacologically active 4'-hydroxylated metabolite of propranolol in the dogD D Christ, U K Walle, J E Oatis, et al.
Pageof 3